ProMIS Neurosciences (PMN) News Today → A once-in-a-century investment opportunity (From Stansberry Research) (Ad) Free PMN Stock Alerts Add Compare Share Share HeadlinesStock AnalysisHeadlinesInsider TradesStock AnalysisHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 1, 2024 | msn.comPMN Stock Earnings: ProMIS Neurosciences Beats EPS for Q4 2023February 22, 2024 | finance.yahoo.comProMIS Neurosciences to Present at the 2024 BIO CEO & Investor ConferenceFebruary 1, 2024 | msn.comNerve stimulation plus physical rehabilitation may boost recovery of arm and hand functionJanuary 8, 2024 | markets.businessinsider.comProMIS Neurosciences Issues Letter to ShareholdersDecember 20, 2023 | finanznachrichten.deProMIS Neurosciences Inc.: ProMIS Neurosciences Announces Publication on Novel Target for ALSNovember 20, 2023 | markets.businessinsider.comProMIS Neurosciences Doses First Subjects in Phase 1a Clinical Trial of PMN310 to Treat Alzheimer’s DiseaseNovember 14, 2023 | finance.yahoo.comProMIS Neurosciences Announces Third Quarter 2023 Financial Results and Recent HighlightsSeptember 8, 2023 | finance.yahoo.comProMIS Neurosciences Closes $20.4 Million Private Placement FinancingAugust 22, 2023 | marketwatch.comProMIS Neurosciences Shares Jump on $20.4 Million Private PlacementAugust 15, 2023 | finanznachrichten.deProMIS Neurosciences Inc.: ProMIS Neurosciences Announces Second Quarter 2023 Financial Results and Recent HighlightsAugust 14, 2023 | finance.yahoo.comProMIS Neurosciences Announces Second Quarter 2023 Financial Results and Recent HighlightsAugust 1, 2023 | seekingalpha.comPMN ProMIS Neurosciences, Inc.July 17, 2023 | marketwatch.comToronto Stocks Edge Lower; ProMIS Neurosciences Soars on Positive Alzheimer's Treatment DataJuly 17, 2023 | msn.comAlzheimer’s Drug Data Sends ProMIS Vaulting UpJuly 17, 2023 | msn.comWhy ProMIS Neurosciences Stock Surged TodayJuly 17, 2023 | msn.comProMIS stock rockets 115% amid preclinical data for Alzheimer's drugJuly 17, 2023 | finance.yahoo.comProMIS Showcases Preclinical Data at the Alzheimer’s Association International Conference 2023 on Computationally-Derived Antibody and Vaccine from Alzheimer’s PipelineJuly 14, 2023 | finance.yahoo.comProMIS Announces Completion of ContinuanceJuly 10, 2023 | finanznachrichten.deProMIS Neurosciences Inc.: ProMIS Neurosciences to Consolidate Trading on the Nasdaq ExchangeJuly 10, 2023 | finance.yahoo.comProMIS Neurosciences to Consolidate Trading on the Nasdaq ExchangeJune 30, 2023 | finance.yahoo.comProMIS Neurosciences Holds Annual Meeting of Shareholders All Resolutions ApprovedJune 29, 2023 | finance.yahoo.comCORRECTION: Updated URL to Access ProMIS Annual Meeting of Shareholders on June 29, 2023 at 9:30am Eastern TimeMay 16, 2023 | finanznachrichten.deProMIS Neurosciences Inc.: ProMIS Neurosciences Announces First Quarter 2023 Financial Results and Recent HighlightsMay 8, 2023 | finance.yahoo.comProMIS Neurosciences Announces FDA Clearance of Investigational New Drug (IND) Application for PMN310 in Alzheimer’s DiseaseApril 27, 2023 | theglobeandmail.comClosing Bell: Promis Neurosciences Inc up on Wednesday (PMN)April 19, 2023 | theglobeandmail.comClosing Bell: Promis Neurosciences Inc down on Wednesday (PMN)April 10, 2023 | proactiveinvestors.comProMIS Neurosciences submits IND application for Alzheimer's treatmentApril 10, 2023 | finance.yahoo.comProMIS Neurosciences Announces Submission of Investigational New Drug (IND) Application for Lead Antibody PMN310March 29, 2023 | finance.yahoo.comLead Therapeutic Candidate, PMN310, Demonstrates Enhanced Selectivity for Toxic Oligomers Compared to Other Amyloid-Beta-Directed Antibodies in Poster Presentation at AD/PD 2023March 13, 2023 | finance.yahoo.comProMIS Neurosciences to Present New Preclinical Data for PMN310 at AD/PD 2023March 13, 2023 | finance.yahoo.comProMIS Neurosciences Announces Abstracts Accepted for Presentation at the American Academy of Neurology 2023 Annual MeetingJanuary 22, 2023 | reuters.comPMN.TO - | Stock Price & Latest News | ReutersOctober 26, 2022 | seekingalpha.comPMN:CA ProMIS Neurosciences, Inc.October 17, 2022 | finance.yahoo.comProMIS Neurosciences, Inc. (PMN)August 15, 2022 | finance.yahoo.comCan ProMIS Neurosciences (TSE:PMN) Afford To Invest In Growth?August 4, 2022 | financialpost.comProMIS Neurosciences Presents at 2022 Alzheimer's Association International ConferenceAugust 2, 2022 | finance.yahoo.comProMIS Neurosciences Presents at 2022 Alzheimer’s Association International ConferenceJuly 27, 2022 | finance.yahoo.comProMIS Neurosciences to Present at 2022 Alzheimer’s Association International ConferenceJuly 15, 2022 | nasdaq.comProMIS Neurosciences Rings the Closing BellJuly 1, 2022 | ca.finance.yahoo.comProMIS at 52-Week HighJune 27, 2022 | finanznachrichten.deProMIS Neurosciences Inc.: ProMIS Neurosciences announces reverse share split to meet NASDAQ listing criteriaJune 27, 2022 | finance.yahoo.comPROMIS ANNOUNCES REVERSE SHARE SPLIT TO MEET NASDAQ LISTING CRITERIAJune 22, 2022 | ca.finance.yahoo.comStocks in play: ProMIS Neurosciences Inc.May 13, 2022 | ca.finance.yahoo.comStocks in play: ProMIS Neurosciences IncMay 13, 2022 | finance.yahoo.comProMIS Neurosciences Announces First Quarter 2022 ResultsMay 13, 2022 | finance.yahoo.comProMIS Holds Annual and Special Meeting of Shareholders All Resolutions ApprovedMay 13, 2022 | finance.yahoo.comCORRECTION: ProMIS Neurosciences Announces First Quarter 2022 ResultsMay 10, 2022 | finance.yahoo.comProMIS Neurosciences (TSE:PMN) Is Using Debt SafelyMay 3, 2022 | finance.yahoo.comIndependent Proxy Advisory Firms, ISS and Glass Lewis, Recommend ProMIS Shareholders Vote FOR All Proposed Items at the Upcoming Annual and Special Meeting of ShareholdersApril 18, 2022 | finance.yahoo.comArgus Research Initiates Equity Report Coverage on ProMIS Neurosciences, Inc. (TSX:PMN & OTCQB: ARFXF) Get ProMIS Neurosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PMN and its competitors with MarketBeat's FREE daily newsletter. Email Address He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (Ad)For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market. Click for his six specific AI stock in the crosshairs PMN Media Mentions By Week PMN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PMN News Sentiment▼0.000.50▲Average Medical News Sentiment PMN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PMN Articles This Week▼00▲PMN Articles Average Week Get ProMIS Neurosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PMN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Small Pharma News Today Microbix Biosystems News Today Aeterna Zentaris News Today IBEX Technologies News Today Aptose Biosciences News Today Covalon Technologies News Today Theratechnologies News Today Ceapro News Today Sirona Biochem News Today Kane Biotech News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:PMN) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchElon’s New Device is About to Shock the WorldInvestorPlaceMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders Alliance[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProMIS Neurosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
